Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertension

Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertension in diabetic hemodialysis patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N217

Enrollment

134

Registered

2024-06-11

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: In the intervention group, empagliflozin 10 mg (low dose) is prescribed every other day to the patients under the supervision of a specialist doctor for a month, and the desired change

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Informed consent Hemodialysis patients with a history of diabetes

Exclusion criteria

Exclusion criteria: History of allergy to empagliflozin

Design outcomes

Primary

Measure	Time frame
Blood sugar. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Diuresis (volume of urine). Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Water. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Electrolyte. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.	—

Measure

Time frame

Blood sugar. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Diuresis (volume of urine). Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Water. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.;Electrolyte. Timepoint: Before starting the study, one month and two months after the end of the study. Method of measurement: Based on laboratory results.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sima Golmohammadian

Kermanshah University of Medical Sciences

s.golmohammadi@kums.ac.ir+98 83 3427 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026